BCAA (the branched-chain amino acids leucine, isoleucine and valine) has been a fixture of sports nutrition for decades, sold as a powder or drink for use during or after training. Brands abroad ask for a Japan-made BCAA product, and increasingly also ask about EAA (all nine essential amino acids) as a newer, broader alternative.
This guide is for brand owners weighing BCAA against EAA or whole protein. It covers what human trials actually show — including the parts of the picture that do not favour BCAA alone — how Japanese products frame these ingredients, and how to formulate either one.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a BCAA or EAA product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Human trials show BCAA alone can raise muscle protein synthesis above placebo after exercise, but the effect is smaller than a complete protein and other essential amino acids without leucine failed to sustain the post-exercise rise that whole protein did.
| Study | Design | Reported result |
|---|---|---|
| Randomised crossover trial, Frontiers in Physiology 2017 (PMID 28638350) | 10 resistance-trained men; 5.6 g BCAA or placebo after a single bout of resistance exercise; muscle biopsies and amino acid tracer infusion | Myofibrillar protein synthesis was 22% higher with BCAA than placebo (0.110%/h v. 0.090%/h) over the 4 hours after exercise; funded by a research grant from the company that supplied the test drinks |
| Controlled trial, The Journal of Physiology 2012 (PMID 22451437) | 24 men; unilateral resistance exercise then 25 g whey, or 6.25 g whey matched to 25 g whey for leucine only, or 6.25 g whey matched for all essential amino acids except leucine | All three drinks raised protein synthesis similarly in the first 1–3 hours; from 3–5 hours after exercise, only the full 25 g whey dose stayed elevated (184% above fasting, against 55% and 35% for the leucine-matched and essential-amino-acid-matched doses) |
| Narrative review, Nutrition Research Reviews 2024;37(2):273–286 (PMID 37681443) | Review of human studies on BCAA and muscle protein synthesis and breakdown | BCAA can activate the cell-signalling pathway for protein synthesis and can transiently raise the synthesis rate, but the stimulatory effect is smaller than the response to a complete protein source providing all essential amino acids |
Four points worth keeping in view:
- The 2012 trial is the clearest head-to-head evidence, and it is not favourable to partial amino acid mixtures. Topping up a small protein dose with only leucine, or with all essential amino acids except leucine, matched a full protein dose for the first few hours but not afterwards. Neither partial mixture is identical to BCAA-only supplementation, but both point the same way: less than the full set of essential amino acids fell short of complete protein once the post-exercise window extended.
- The 2017 trial used BCAA against a placebo, not against EAA or whole protein, so a positive result there does not settle the comparison — it shows BCAA does something, not that BCAA does as much as a complete protein.
- The 2017 trial was industry-funded and small. It was supported by a research grant from the company that supplied both the BCAA drink and the placebo, and it enrolled 10 men.
- The 2024 review reaches the same conclusion from the wider literature: BCAA’s effect on the synthesis rate is real but smaller than complete protein’s.
Checked against the published abstracts and the 2017 trial’s funding statement on 12 October 2026.
What Japanese products say
In Japan, BCAA and EAA are sold as ordinary food and sports-nutrition ingredients, not as medicines, and label wording for exercise-related products tends to describe them by amount rather than by a specific claimed function.
Amino acids including the branched-chain amino acids and the other essential amino acids are common ingredients in Japanese sports drinks, powders and tablets, sold under Japan’s general food rules rather than as medicines. A brand that wants to use Japan’s Foods with Function Claims framework for a BCAA or EAA product needs its own notification, supported by its own evidence, submitted to the Consumer Affairs Agency before sale.
💬 Need an evidence summary for your regulatory adviser that separates what the trials show for BCAA alone from what they show for EAA and whole protein? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe BCAA and EAA by what has been studied and under what conditions, not as a substitute for complete protein.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for muscle protein synthesis after resistance exercise" | "Builds more muscle than protein” or “replaces protein" |
| "Contains BCAA” or “contains all nine essential amino acids” with the amount per serving | Claims that BCAA alone maximises muscle growth |
| Naming the study and its result, including where the effect was smaller than complete protein | ”Clinically proven” without naming the study and its limits |
How BCAA and EAA are formulated
Both BCAA and EAA are water-soluble amino acid blends dosed in grams, which puts them in a powder, drink or tablet rather than a small daily capsule.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Powder for mixing | The standard format for gram-level doses; flexible for flavouring | Solubility, bitterness and flavour masking |
| Ready-to-drink or drink stick | Convenient for use during or after training | Stability of the amino acid blend and flavour system over shelf life |
| Tablet or capsule | Familiar format, no mixing needed | Gram-level doses need several tablets, which raises pack size and cost per serving |
Decisions that shape the specification:
- The amino acid ratio. BCAA blends are typically described by a leucine-isoleucine-valine ratio; EAA blends must specify the amount of all nine essential amino acids. Match the ratio and total amount to any study you intend to cite, and be specific about which one — BCAA alone, or the fuller essential amino acid set — your product actually contains.
- Solubility and bitterness. Amino acids in this dose range are notably bitter, and solubility varies by amino acid. This is the main formulation challenge for a powder or drink, and usually needs flavour masking and an experienced factory.
- Companion ingredients. BCAA and EAA are often combined with electrolytes, citrulline or carbohydrate in sports products. Each companion ingredient needs its own check against Japanese food law.
- Dosage form and your market. A powder suits a training-use product; a tablet suits an everyday, low-dose positioning. Confirm BCAA and EAA’s status as food ingredients in your own market before you commit to a formula.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
BCAA and the other essential amino acids are themselves widely used in Japanese foods. Sports-nutrition formulas that add other actives — stimulants, certain botanicals — are where a companion ingredient most often causes a problem. See the Japan-made supplement OEM page, and compare with our creatine and HMB guides if you are formulating a wider sports-nutrition range.
Before you ask for a quotation
A factory can quote accurately once the amino acid profile, the form, the companions and the packaging are fixed.
- Whether the product is BCAA alone, EAA, or a combined formula, and the exact ratio
- Amount per serving and servings per pack
- Dosage form, and flavour if powder or drink
- Companion ingredients and their amounts
- Packaging
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made BCAA or EAA product? Send us the concept — amino acid profile, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Is BCAA alone as good as EAA or whole protein for building muscle?
The evidence is mixed. A 2012 controlled trial found that topping up a small protein dose with only leucine, or with essential amino acids minus leucine, matched a full protein dose for the first few hours after exercise but not from 3–5 hours, when only the complete protein stayed elevated. A 2024 review of the wider literature reached a similar conclusion: BCAA’s effect on muscle protein synthesis is real but smaller than a complete protein’s.
2. Does BCAA do anything on its own?
Yes. A 2017 trial in resistance-trained men found that 5.6 g of BCAA alone raised muscle protein synthesis 22% above a placebo drink after exercise. That trial compared BCAA with nothing, not with EAA or whole protein, so it shows BCAA has an effect, not that it matches a complete protein. It was also small and funded by the company that supplied the test drinks.
3. What is the difference between BCAA and EAA?
BCAA is three amino acids — leucine, isoleucine and valine. EAA is all nine essential amino acids, including those three. A complete protein such as whey contains the full set of essential amino acids plus the non-essential ones.
4. Why is BCAA/EAA formulated as a powder rather than a capsule?
The doses used in trials are in the gram range, which is impractical to fit into a small number of capsules. Powders and drinks are the standard formats, though tablets are used for lower everyday doses.
5. What is the main formulation challenge with BCAA and EAA?
Bitterness and solubility. Amino acids at this dose are notably bitter and vary in how well they dissolve, so flavour masking is usually the deciding factor in whether a powder or drink succeeds.
Sources: “Branched-Chain Amino Acid Ingestion Stimulates Muscle Myofibrillar Protein Synthesis following Resistance Exercise in Humans”, Frontiers in Physiology 2017 (PMID 28638350; PMC5461297); “Supplementation of a suboptimal protein dose with leucine or essential amino acids: effects on myofibrillar protein synthesis at rest and following resistance exercise in men”, The Journal of Physiology 2012 (PMID 22451437); “The effects of branched-chain amino acids on muscle protein synthesis, muscle protein breakdown and associated molecular signalling responses in humans: an update”, Nutrition Research Reviews 2024;37(2):273–286 (PMID 37681443). Checked on 12 October 2026.